RxDoctor Payments Data

Susan Paldino, APRN

Adult Health · Monroe, CTNPI 1689018582

Payments from drug & device makers

$660in general payments, 2019–2025

Across 32 payments — averaging $20.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$175
  • Exact Sciences$94
  • Lilly USA, LLC$86
  • Otsuka America Pharmaceutical, Inc.$56
  • AstraZeneca$56
  • Neurocrine Biosciences, Inc.$46
  • plus $148 from 6 others

What the payments were for

  • Food & beverage$660100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$660 in reported general payments places this provider in the 60th percentile of 418 adult health providers in Connecticut.

See all adult health providers in Connecticut

Medicare billing

Part B allowed, 2024
$38,800
Medicare patients
166
Services billed
373

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban118$44,998
JanuviaSitagliptin Phosphate44$21,832
JardianceEmpagliflozin42$19,035
XareltoRivaroxaban41$13,556
Brimonidine Tartrate13$1,984
Memantine Hcl ErMemantine Hcl13$1,754
Travoprost11$1,619
Metoprolol Succinate91$1,535
Mirtazapine62$1,521
Atorvastatin Calcium90$1,482
Sertraline Hcl67$1,461
Trazodone Hcl90$1,154
Potassium Chloride45$1,083
Buspirone Hcl22$1,020
Carvedilol36$809

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$46$44,998118 claims
Boehringer IngelheimJardiance$20$19,03542 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 418 adult health providers in Connecticut.

Other adult health in Monroe

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →